1. Home
  2. IGIC vs SPRY Comparison

IGIC vs SPRY Comparison

Compare IGIC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International General Insurance Holdings Ltd.

IGIC

International General Insurance Holdings Ltd.

N/A

Current Price

$24.24

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$8.88

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IGIC
SPRY
Founded
2001
2015
Country
Jordan
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
IGIC
SPRY
Price
$24.24
$8.88
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$28.00
$35.00
AVG Volume (30 Days)
50.4K
902.7K
Earning Date
01-01-0001
06-12-2026
Dividend Yield
0.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
$0.13
N/A
Revenue Next Year
$2.54
$119.97
P/E Ratio
$9.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.82
$6.66
52 Week High
$27.63
$18.63

Technical Indicators

Market Signals
Indicator
IGIC
SPRY
Relative Strength Index (RSI) 38.53 39.34
Support Level $22.68 $8.61
Resistance Level $24.26 $10.44
Average True Range (ATR) 0.84 0.45
MACD -0.15 0.02
Stochastic Oscillator 30.19 19.07

Price Performance

Historical Comparison
IGIC
SPRY

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: